December 25th 2019, 2:00am
Patients with multiple myeloma have a lot to look forward to in the treatment space thanks to precision medicine, but one treatment option alone will not cure the disease.
December 21st 2019, 3:00am
At the 2019 CURE® Educated Patient® Summit on Multiple Myeloma patient advocate and 10-year survivor Terry White had the chance to share advice on handling a cancer diagnosis.
December 20th 2019, 3:00am
Naturally, newly diagnosed patients with multiple myeloma have a lot of questions for their physicians. Dr. Joshua Richter had the time to discuss some of them.
December 16th 2019, 12:52am
At CURE’s Educated Patient Summit on Multiple Myeloma Dr. Shebli Atrash had the chance to further discuss with CURE what questions he addresses most when patients with multiple myeloma undergo diagnostic testing.
December 15th 2019, 9:57pm
At CURE’s Educated Patient Summit on Multiple Myeloma, Dr. Barry Paul discussed the role of minimal residual disease measurement and how it may be used in the future to determine treatment options for patients with myeloma.
December 15th 2019, 2:11am
Dr. Cesar Rodriguez offers a message of hope and self-determination for patients with multiple myeloma.
Knowledge Isn’t Enough When Action Costs Too Much
What Does Minimal Residual Disease Mean?
Preoperative Breast MRI Did Not Improve Outcomes in Early-Stage Breast Cancer
Enhertu/Perjeta Combo Enhances Quality of in HER2+ Advanced Breast Cancer